ATC Group: B02BD03 Factor VIII inhibitor bypassing activity

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B02BD03 in the ATC hierarchy

Level	Code	Title
1	B	Blood and blood forming organs
2	B02	Antihemorrhagics
3	B02B	Vitamin K and other hemostatics
4	B02BD	Blood coagulation factors
5	B02BD03	Factor VIII inhibitor bypassing activity

Active ingredients in B02BD03

Active Ingredient	Description
Factor VIII inhibitor bypass activity

Related product monographs

Title	Information Source	Document Type
FEIBA Powder and solvent for solution for infusion	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

(combination) FEIBA

Brazil (BR)

(combination) FEIBA

Canada (CA)

(combination) FEIBA

Croatia (HR)

(combination) FEIBA

Ecuador (EC)

(combination) FEIBA

Estonia (EE)

(combination) FEIBA

Finland (FI)

(combination) FEIBA

France (FR)

(combination) FEIBA

Hong Kong (HK)

(combination) FEIBA

Ireland (IE)

(combination) FEIBA

Israel (IL)

(combination) FEIBA

Japan (JP)

(combination) FEIBA

Lithuania (LT)

(combination) FEIBA

Malta (MT)

(combination) FEIBA

Netherlands (NL)

(combination) FEIBA

New Zealand (NZ)

(combination) FEIBA

Poland (PL)

(combination) FEIBA

Romania (RO)

(combination) FEIBA

Singapore (SG)

(combination) FEIBA

South Africa (ZA)

(combination) FEIBA

Spain (ES)

(combination) FEIBA

Tunisia (TN)

(combination) FEIBA

Turkey (TR)

(combination) FEIBA

United Kingdom (UK)

(combination) FEIBA

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

Go to ATC index